Brief: Dermapharm Holding FY Adjusted Group EBITDA Up At EUR 351 Mln

Dermapharm Holding SE

22/03/2022 06:36

March 22 (Reuters) - DERMAPHARM HOLDING SE  DMPG.DE :
    * MOST SUCCESSFUL BUSINESS YEAR IN THE COMPANY'S HISTORY -
ADJUSTED GROUP EBITDA AT THE UPPER END OF THE OUTLOOK
    * GROUP REVENUE INCREASED BY 19% TO EUR 943 MILLION IN 2021
FINANCIAL YEAR (PREVIOUS YEAR: EUR 794 MILLION)
    * FY ADJUSTED GROUP EBITDA MARGIN OF 37.2%
    * FY ADJUSTED GROUP EBITDA INCREASED BY AROUND 75% TO EUR
351
MILLION

Source text for Eikon:  ID:nEQ5b7RwDa 
Further company coverage:  DMPG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))